It belongs to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Mounjaro has received significant attention because it works through two distinct hormone pathways involved in appetite and blood sugar regulation
For more details on the activities of NPY and PYY see the Gut-Brain Interrelationships and the Control of Feeding Behaviors page
Individual weight loss goals : Some patients are stratified with minor weight loss changes and do not aim to lose a lot of weight
Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants with Vascular Disease (VERTIS-CV), which compared ertugliflozin with placebo showed non-inferiority in regards to its primary MACE outcome, as well as a 30% reduction in HHF [41]
Pannacciulli N, Le DS, Salbe AD, Chen K, Reiman EM, Tataranni PA, et al